跳至主要内容
临床试验/NCT00363740
NCT00363740已完成3 期

Clinical Evaluation of GW685698 for Seasonal Allergic Rhinitis -A Placebo-controlled Study to Determine the Non-inferiority of GW685698 Over Fluticasone Propionate Using a Double-blind Manner-

GlaxoSmithKline1 个研究点目标入组 38 人开始时间: 2005年2月19日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
38
试验地点
1
主要终点
Mean change from baseline over the entire treatment period in three total nasal symptom scores.

研究概览

简要总结

This study was designed to compare the efficacy and safety of an investigational nasal spray compared with placebo nasal spray and commonly used drug in the treatment of seasonal allergic rhinitis. Allergic rhinitis is an inflammatory disorder of the upper airway that occurs following allergen exposure. The focus of this study, seasonal allergic rhinitis (SAR), is one type of allergic rhinitis that is triggered by the pollen from trees, grasses, and weeds. Typical symptoms are sneezing, nasal congestion and pruritus, rhinorrhea, and pruritic, watery, red eyes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Significant concomitant medical condition
  • Use of corticosteroids/allergy medications
  • Laboratory abnormality
  • Positive pregnancy test
  • Allergy to any component of investigational product

结局指标

主要结局

Mean change from baseline over the entire treatment period in three total nasal symptom scores.

次要结局

  • Mean change from baseline over the entire treatment period in four total nasal symptom scores.
  • Mean change from baseline over the entire treatment period in individual total nasal symptom scores.

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验